Advanced company searchLink opens in new window

CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Company number 09686738

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Sep 2017 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES10 ‐ Resolution of allotment of securities
25 Jul 2017 CS01 Confirmation statement made on 14 July 2017 with updates
22 May 2017 TM01 Termination of appointment of Andrew Peter Walsh as a director on 15 May 2017
22 May 2017 AP01 Appointment of Dr Anne Michelle Dobrée as a director on 15 May 2017
28 Apr 2017 RP04SH01 Second filing of a statement of capital following an allotment of shares on 3 November 2015
  • GBP 19,589.56
12 Apr 2017 AA Total exemption small company accounts made up to 31 July 2016
20 Dec 2016 SH08 Change of share class name or designation
23 Sep 2016 CH01 Director's details changed for Dr Kevin Stuart Johnson on 20 September 2016
23 Sep 2016 CH01 Director's details changed for Dr David John Grainger on 20 September 2016
18 Jul 2016 CS01 Confirmation statement made on 14 July 2016 with updates
25 Jan 2016 AD01 Registered office address changed from C/O Index Ventures (Uk) Llp 3 Burlington Gardens Mayfair London W1S 3EP England to Moneta Building Babraham Research Campus Cambridge CB22 3AT on 25 January 2016
20 Jan 2016 AP01 Appointment of Kevin Stuart Johnson as a director on 30 October 2015
18 Jan 2016 SH01 Statement of capital following an allotment of shares on 27 November 2015
  • GBP 22,052.25
28 Nov 2015 AP01 Appointment of Andrew Peter Walsh as a director on 30 October 2015
28 Nov 2015 AP01 Appointment of Dr Robert Giles Tansley as a director on 30 October 2015
26 Nov 2015 AP01 Appointment of Professor Nicholas Morrell as a director on 30 October 2015
24 Nov 2015 SH01 Statement of capital following an allotment of shares on 3 November 2015
  • GBP 19,589.56
  • ANNOTATION Clarification a second filed SH01 was registered on 28/04/2017
24 Nov 2015 SH08 Change of share class name or designation
24 Nov 2015 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
  • RES12 ‐ Resolution of varying share rights or name
15 Jul 2015 NEWINC Incorporation
Statement of capital on 2015-07-15
  • GBP .01